Skip to main content
Home
Insights
Insight
Enhancing resilience in GCC pharma & biotech through R&D
Insights by Raviraj Dande, Director, Healthcare Consulting – MENA at JLL
Economics
Investment sales and advisory
Healthcare property
Life Sciences
Convert to PDF
Building self-resilience in the GCC pharmaceutical and biotechnology sector through advanced research and development
Challenges in the GCC pharmaceutical and biotech sector
GCC’s roadmap to overcome challenges, propel R&D, and become global leaders in pharma and biotech
Prioritizing investment in R&D
Building a world-class workforce
Strengthening intellectual property (IP) framework and regulations
Prioritizing biotechnology for a self-sufficient pharmaceutical industry
Looking for more insights? Never miss an update.
Looking for more insights? Never miss an update.
The latest news, insights and opportunities from global commercial real estate markets straight to your inbox.
Subscribe
